Table 2.
The Prevalence of Sarcopenia Status by Age Groups and Gender
| Age Groups | Without SARCOPENIA (n=1132) | Confirmed Sarcopenia (n=275) | |||||
|---|---|---|---|---|---|---|---|
| Total* n (%) | Non-Sarcopenia n (%) | Possible Sarcopenia n (%) | Total** n (%) | Sarcopenia n (%) | Severe Sarcopenia n (%) | ||
| Total | 65–69 (n=572) | 503 (87.9) | 426 (74.5) | 77 (13.5) | 69 (12.1) | 55 (9.6) | 14 (2.4) |
| 70–74 (n=436) | 360 (82.6) | 279 (64.0) | 81 (18.6) | 76 (17.4) | 51 (11.7) | 25 (5.7) | |
| 75–79 (n=234) | 173 (73.9) | 111 (47.4) | 62 (26.5) | 61 (26.1) | 32 (13.7) | 29 (12.4) | |
| ≥80 (n=165) | 96 (58.2) | 39 (23.6) | 57 (34.5) | 69 (41.8) | 29 (17.6) | 40 (24.2) | |
| Female | 65–69 (n=367) | 329 (89.6) | 271 (73.8) | 58 (15.8) | 38 (10.4) | 31 (8.4) | 7 (1.9) |
| 70–74 (n=248) | 209 (84.3) | 160 (64.5) | 49 (19.8) | 39 (15.7) | 25 (10.1) | 14 (5.6) | |
| 75–79 (n=122) | 93 (76.2) | 51 (41.8) | 42 (34.4) | 29 (23.8) | 15 (12.3) | 14 (11.5) | |
| ≥80 (n=89) | 54 (60.7) | 20 (22.5) | 34 (38.2) | 35 (39.3) | 12 (13.5) | 23 (25.8) | |
| Male | 65–69 (n=205) | 174 (84.9) | 155 (75.6) | 19 (9.3) | 31 (15.1) | 24 (11.7) | 7 (3.4) |
| 70–74 (n=188) | 151 (80.3) | 119 (63.3) | 32 (17.0) | 37 (19.7) | 26 (13.8) | 11 (5.9) | |
| 75–79 (n=112) | 80 (71.4) | 60 (53.6) | 20 (17.9) | 32 (28.6) | 17 (15.2) | 15 (13.4) | |
| ≥80 (n=76) | 42 (55.3) | 19 (25.0) | 23 (30.3) | 34 (44.7) | 17 (22.4) | 17 (22.4) | |
Notes: *Prevalence of without sarcopenia = prevalence of non-sarcopenia + prevalence of possible sarcopenia. **Prevalence of confirmed sarcopenia = prevalence of sarcopenia + prevalence of severe sarcopenia.